Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick M Beardsley

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Metabolomics : Official Journal of the Metabolomic Society|April 5, 2013
Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposureJoseph L McClay, Daniel E Adkins, Sarah A Vunck, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2016
Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in MiceRobert A Owens, Bogna Ignatowska-Jankowska, Mohammed Mustafa, et al.
Neuropharmacology|July 5, 2017
Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB<sub>1</sub> receptor-mediated discriminative stimulus in miceRobert A Owens, Mohammed A Mustafa, Bogna M Ignatowska-Jankowska, et al.
Neuroscience Letters|January 25, 2017
Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1bRachel M Enga, Ann C Rice, Pamela Weller, et al.
European Journal of Pharmacology|November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorderYi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaineAlan P Kozikowski, Kenneth M Johnson, Olivier Deschaux, et al.
Cell Reports|October 23, 2021
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in miceMario de la Fuente Revenga, Bohan Zhu, Christopher A Guevara, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 26, 2010
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophreniaJoseph L McClay, Daniel E Adkins, Karolina Aberg, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Metabolomics : Official Journal of the Metabolomic Society|April 5, 2013
Large-scale neurochemical metabolomics analysis identifies multiple compounds associated with methamphetamine exposureJoseph L McClay, Daniel E Adkins, Sarah A Vunck, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2016
Discriminative Stimulus Properties of the Endocannabinoid Catabolic Enzyme Inhibitor SA-57 in MiceRobert A Owens, Bogna Ignatowska-Jankowska, Mohammed Mustafa, et al.
Neuropharmacology|July 5, 2017
Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB<sub>1</sub> receptor-mediated discriminative stimulus in miceRobert A Owens, Mohammed A Mustafa, Bogna M Ignatowska-Jankowska, et al.
Neuroscience Letters|January 25, 2017
Initial characterization of behavior and ketamine response in a mouse knockout of the post-synaptic effector gene Anks1bRachel M Enga, Ann C Rice, Pamela Weller, et al.
European Journal of Pharmacology|November 20, 2019
Pharmacological characterization of 17-cyclopropylmethyl-3,14-dihydroxy-4,5-epoxy-6-[(3'-fluoro-4'-pyridyl)acetamido]morphinan (NFP) as a dual selective MOR/KOR ligand with potential applications in treating opioid use disorderYi Zheng, Samuel Obeng, Bethany A Reinecke, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2003
Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaineAlan P Kozikowski, Kenneth M Johnson, Olivier Deschaux, et al.
Cell Reports|October 23, 2021
Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in miceMario de la Fuente Revenga, Bohan Zhu, Christopher A Guevara, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 26, 2010
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophreniaJoseph L McClay, Daniel E Adkins, Karolina Aberg, et al.
Pageof 7